We’re uniting with Invitae to create a global leader in comprehensive genetics and precision oncology.  Read More

We’re Right Where
You Need Us

We are a leading genomic analysis company democratizing precision oncology

The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.

We provide a powerful product development platform for research that enables all molecular laboratories to solve complex genomic problems.

Our ultimate goal is to break down barriers to sophisticated genomic analysis in community and regional settings with our in vitro diagnostic (IVD) products that are currently in development.
ArcherDX aims to address barriers to bringing precision oncology to patients, anywhere
We are in 40+
Countries
We provide expansive
access
Latest news from ArcherDX

June 22, 2020

Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

June 18, 2020

ArcherDX Enters Collaboration With Bristol Myers Squibb To Apply Personalized Cancer Monitoring (PCM™) To Clinical Research

May 26, 2020

ArcherDX Announces Strategic Collaboration With AstraZeneca To Develop Personalized Cancer Monitoring (PCM™) Assays For Minimal Residual Disease (MRD)